Epidemiology of Streptococcus pneumoniae infections at the Edinburgh City Hospital: 1980-95

Epidemiology and Infection

Volumn 122, Issue 2, 1999, Pages 251-257

  Kalima, P ^a,b   Emmanuel, F X S ^a   Riordan, T ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Public Health Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD CULTURE; CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PENICILLIN RESISTANCE; SEASONAL VARIATION; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD; CHILD, PRESCHOOL; ERYTHROMYCIN; HIV INFECTIONS; HOSPITALS, URBAN; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; PNEUMOCOCCAL INFECTIONS; SCOTLAND; SEASONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0032934637     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899002125     Document Type: Article

References (31)

1. Macfarlane JT. Community-acquired pneumonia. Br J Dis Chest 1987; 81: 116-27.
2. Leowski J. Mortality from acute respiratory infections in children less than 5 years of age: global estimates. World Health Statist Q 1986; 39: 138-44.
3. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96.
4. Gould GA, Rhind GB, Morgan AD, Williamson G, Calder MA. Pneumococcal serotypes in sputum isolates during acute respiratory illness in Edinburgh. Thorax 1987; 42: 589-92.
5. Speigel MR. Analysis of time series. In: Schaum's outline series: theory and problems of statistics. McGraw Inc. 1991; 18: 398-433.
6. Scott JAG, Hall AJ, Dagan R, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: association with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis 1996; 22: 973-81.
7. Smart LE, Dougall AJ, Girdwood RWA. New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease. J Infect 1987; 14: 209-15.
8. Johnson AP, Speller DC. Antibiotic resistance. Epidemiology of antibiotic resistance: blood and cerebrospinal fluid (CSF). J Med Microbiol 1997; 46: 445-7.
9. Ridgway EJ, Tremlett CH, Allen KD. Capsular serotypes and antibiotic sensitivity of Streptococcus pneumoniae isolated from primary-school children. J Infect 1995; 30: 245-51.
10. Boswell TCJ, Frodsham D, Nye KJ, Smith EG. Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham Public Health Laboratory, 1989-1994. J Infect 1996; 33: 17-22.
11. Klein DL. Pneumococcal conjugate vaccines: review and update. Microbial Drug Resist 1995; 1: 49-58.
12. Verhaegen J, Glupczynski Y, Verbist L, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis 1995; 20: 1339-45.
13. Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect 1996; 117: 411-6.
14. Eby R. Pneumococcal conjugate vaccines. In: Powell MF, Neumans MJ, eds. Vaccine design: the subunit and adjuvant approach. New York: Plenum Press, 1995: 695-718.
15. Butler JC. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. Microbial Drug Resist 1997; 3: 125-9.
16. Sniadack DH, Schwartz B, Lipman H, et al. Potential interventions for the prevention of childhood pneumonia : geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children - implications for vaccine strategies. Pediatr Infect Dis J 1995; 14: 503-10.
17. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996; 174: 1271-8.
18. Obaro SK, Adegbola RA, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996; 348: 271-2.
19. Musher DM. Streptococcus pneumoniae. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone Inc. 1995: 1811-26.
20. Pesola GR, Charles A. Pneumococcal bacteremia with pneumonia: mortality in acquired immunodeficiency syndrome. Chest 1992; 101: 150-5.
21. Kim PE, Musher MD, Glezen WP, Rodriguez Barradas MC, Nahm WK, Wright CE. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 1996; 22: 100-6.
22. Morgan AD, Rhind GB, Connaughton JJ, Calder MA. Pneumococcal serotyping and antigen detection in pneumonia in adults. J Infect 1984; 9: 134-8.
23. Hibbs JR, Douglas Jr. JM, Judson FN, McGill WL, Reitmiejer CAM, Janoff EN. Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994. Clin Infect Dis 1997; 25: 195-9.
24. Foster JA, McGowan KL. Rising rate pneumococcal bacteria at the Children's Hospital of Philadelphia. Pediatr Infect Dis J 1994; 13: 1143-4.
25. Burns SM, Brettle RP, Gore SM, Peutherer JF, Roy Robertson J. The epidemiology of HIV Infection in Edinburgh related to the injecting drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum. J Infect 1996; 32: 53-62.
26. Redd SC, Rutherford III GW, Sande MA, et al. The role of human immunodeficiency virus in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990; 162: 1012-7.
27. Schuchat A, Broome CV, Hightower A, Costa SJ, Parkin W. Use of surveillance of invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population. JAMA 1991; 265: 3275-9.
28. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection: epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992; 117: 314-24.
29. Gilks C, Ojoo SA, Ojoo JC, et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 1996; 347: 718-23.
30. Perkin MJ, Helbert M, Hughes CL, Pinching AJ. Immunoglobulin G subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS. AIDS 1989; 3: 37-9.
31. Johnson AP, Speller DCE, George RC, Warner M, Domingue G, Efstratiou A. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ 1996; 312: 1454-6.